Infectious complications in chronic graft-versus-host disease: A retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens

S. Yamasaki, Y. Heike, S. Mori, T. Fukuda, D. Maruyama, R. Kato, E. Usui, K. Koido, S. Kim, Ryuji Tanosaki, K. Tobinai, T. Teshima, Y. Takaue

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

To assess infectious complications associated with chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) with reduced- and conventional-intensity conditioning regimens (RIC, n=91; CIC, n=54, respectively), we retrospectively analyzed data from 145 consecutive patients with cGVHD after allogeneic HSCT from a human leukocyte antigen-matched related or unrelated donor. In the present retrospective analysis, 57% (83/145) of patients with cGVHD developed infections, with a mortality rate of 27% (22/83). The incidences of bacteremia (n=28), central venous catheter-related infections (n=11), bacterial pneumonia (n=4), invasive aspergillosis (n=7), and adenoviral hemorrhagic cystitis (n=8) were significantly higher in patients with prednisolone dose ≥1 mg/kg at the time of diagnosis of cGVHD. The present results suggest that infections associated with cGVHD, especially after high-dose prednisolone, are predictive of poor outcome regardless of whether the patient received RIC or CIC.

Original languageEnglish
Pages (from-to)252-259
Number of pages8
JournalTransplant Infectious Disease
Volume10
Issue number4
DOIs
Publication statusPublished - 2008 Aug
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Retrospective Studies
Prednisolone
Bacterial Pneumonia
Catheter-Related Infections
Unrelated Donors
Aspergillosis
Cystitis
Central Venous Catheters
HLA Antigens
Bacteremia
Infection
Mortality
Incidence

Keywords

  • Allogeneic hematopoietic stem cell transplantation
  • Chronic graft-versus-host disease
  • HLA-matched donor
  • Infectious complication
  • Reduced-intensity conditioning

ASJC Scopus subject areas

  • Transplantation
  • Microbiology (medical)
  • Immunology

Cite this

Infectious complications in chronic graft-versus-host disease : A retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens. / Yamasaki, S.; Heike, Y.; Mori, S.; Fukuda, T.; Maruyama, D.; Kato, R.; Usui, E.; Koido, K.; Kim, S.; Tanosaki, Ryuji; Tobinai, K.; Teshima, T.; Takaue, Y.

In: Transplant Infectious Disease, Vol. 10, No. 4, 08.2008, p. 252-259.

Research output: Contribution to journalArticle

Yamasaki, S. ; Heike, Y. ; Mori, S. ; Fukuda, T. ; Maruyama, D. ; Kato, R. ; Usui, E. ; Koido, K. ; Kim, S. ; Tanosaki, Ryuji ; Tobinai, K. ; Teshima, T. ; Takaue, Y. / Infectious complications in chronic graft-versus-host disease : A retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens. In: Transplant Infectious Disease. 2008 ; Vol. 10, No. 4. pp. 252-259.
@article{7c3616669b5d4c979f0f4da96226e1b3,
title = "Infectious complications in chronic graft-versus-host disease: A retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens",
abstract = "To assess infectious complications associated with chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) with reduced- and conventional-intensity conditioning regimens (RIC, n=91; CIC, n=54, respectively), we retrospectively analyzed data from 145 consecutive patients with cGVHD after allogeneic HSCT from a human leukocyte antigen-matched related or unrelated donor. In the present retrospective analysis, 57{\%} (83/145) of patients with cGVHD developed infections, with a mortality rate of 27{\%} (22/83). The incidences of bacteremia (n=28), central venous catheter-related infections (n=11), bacterial pneumonia (n=4), invasive aspergillosis (n=7), and adenoviral hemorrhagic cystitis (n=8) were significantly higher in patients with prednisolone dose ≥1 mg/kg at the time of diagnosis of cGVHD. The present results suggest that infections associated with cGVHD, especially after high-dose prednisolone, are predictive of poor outcome regardless of whether the patient received RIC or CIC.",
keywords = "Allogeneic hematopoietic stem cell transplantation, Chronic graft-versus-host disease, HLA-matched donor, Infectious complication, Reduced-intensity conditioning",
author = "S. Yamasaki and Y. Heike and S. Mori and T. Fukuda and D. Maruyama and R. Kato and E. Usui and K. Koido and S. Kim and Ryuji Tanosaki and K. Tobinai and T. Teshima and Y. Takaue",
year = "2008",
month = "8",
doi = "10.1111/j.1399-3062.2007.00291.x",
language = "English",
volume = "10",
pages = "252--259",
journal = "Transplant Infectious Disease",
issn = "1398-2273",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Infectious complications in chronic graft-versus-host disease

T2 - A retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens

AU - Yamasaki, S.

AU - Heike, Y.

AU - Mori, S.

AU - Fukuda, T.

AU - Maruyama, D.

AU - Kato, R.

AU - Usui, E.

AU - Koido, K.

AU - Kim, S.

AU - Tanosaki, Ryuji

AU - Tobinai, K.

AU - Teshima, T.

AU - Takaue, Y.

PY - 2008/8

Y1 - 2008/8

N2 - To assess infectious complications associated with chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) with reduced- and conventional-intensity conditioning regimens (RIC, n=91; CIC, n=54, respectively), we retrospectively analyzed data from 145 consecutive patients with cGVHD after allogeneic HSCT from a human leukocyte antigen-matched related or unrelated donor. In the present retrospective analysis, 57% (83/145) of patients with cGVHD developed infections, with a mortality rate of 27% (22/83). The incidences of bacteremia (n=28), central venous catheter-related infections (n=11), bacterial pneumonia (n=4), invasive aspergillosis (n=7), and adenoviral hemorrhagic cystitis (n=8) were significantly higher in patients with prednisolone dose ≥1 mg/kg at the time of diagnosis of cGVHD. The present results suggest that infections associated with cGVHD, especially after high-dose prednisolone, are predictive of poor outcome regardless of whether the patient received RIC or CIC.

AB - To assess infectious complications associated with chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) with reduced- and conventional-intensity conditioning regimens (RIC, n=91; CIC, n=54, respectively), we retrospectively analyzed data from 145 consecutive patients with cGVHD after allogeneic HSCT from a human leukocyte antigen-matched related or unrelated donor. In the present retrospective analysis, 57% (83/145) of patients with cGVHD developed infections, with a mortality rate of 27% (22/83). The incidences of bacteremia (n=28), central venous catheter-related infections (n=11), bacterial pneumonia (n=4), invasive aspergillosis (n=7), and adenoviral hemorrhagic cystitis (n=8) were significantly higher in patients with prednisolone dose ≥1 mg/kg at the time of diagnosis of cGVHD. The present results suggest that infections associated with cGVHD, especially after high-dose prednisolone, are predictive of poor outcome regardless of whether the patient received RIC or CIC.

KW - Allogeneic hematopoietic stem cell transplantation

KW - Chronic graft-versus-host disease

KW - HLA-matched donor

KW - Infectious complication

KW - Reduced-intensity conditioning

UR - http://www.scopus.com/inward/record.url?scp=47849101629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47849101629&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3062.2007.00291.x

DO - 10.1111/j.1399-3062.2007.00291.x

M3 - Article

C2 - 18194371

AN - SCOPUS:47849101629

VL - 10

SP - 252

EP - 259

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

SN - 1398-2273

IS - 4

ER -